ATC Group: J01AA08 Minocycline

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01AA08 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01A Tetracyclines
4 J01AA Tetracyclines
5 J01AA08 Minocycline

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.2 g
PAREN - Parenteral 0.2 g

Active ingredients in J01AA08

Active Ingredient Description
Minocycline

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.

Related product monographs

Title Information Source Document Type  
ACNAMINO MR Capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MINOCIN SA Modified release hard capsule Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Cyprus (CY)

Estonia (EE)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.